211
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles

, , , , , , & show all
Pages 5625-5635 | Published online: 21 Sep 2018

References

  • LowesMABowcockAMKruegerJGPathogenesis and therapy of psoriasisNature2007445713086687317314973
  • SlominskiATZmijewskiMASkobowiatCZbytekBSlominskiRMSteketeeJDSensing the environment: regulation of local and global homeostasis by the skin’s neuroendocrine systemAdv Anat Embryol Cell Biol20122121115
  • SlominskiATZmijewskiMAZbytekBTobinDJTheoharidesTCRivierJKey role of CRF in the skin stress response systemEndocr Rev201334682788423939821
  • NestleFOKaplanDHBarkerJMechanisms of disease: PsoriasisN Engl J Med200936149650919641206
  • SinghTPZhangHHBorekIMonocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammationNat Commun201671358127982014
  • YoshikiRKabashimaKHondaTIL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cellsJ Invest Dermatol201413471912192124569709
  • HartwigTPantelyushinSCroxfordALKuligPBecherBDermal IL-17-producing γδ T cells establish long-lived memory in the skinEur J Immunol20151130223033
  • MasonARMasonJCorkMDooleyGHancockHTopical treatments for chronic plaque psoriasisCochrane Database Syst Rev20133CD005028
  • ProwTWGriceJELinLLNanoparticles and microparticles for skin drug deliveryAdv Drug Deliv Rev201163647049121315122
  • ZhaiYZhaiGAdvances in lipid-based colloid systems as drug carrier for topic deliveryJ Control Release2014193909924939745
  • LowesMASuárez-FariñasMKruegerJGImmunology of psoriasisAnnu Rev Immunol20143222725524655295
  • LinYKYangSHChenCCKaoHCFangJYUsing imiquimod-induced psoriasis-like skin as a model to measure the skin penetration of anti-psoriatic drugsPLoS One2015109e013789026355594
  • van der FitsLMouritsSVoermanJSImiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axisJ Immunol200918295836584519380832
  • SunJZhaoYHuJCurcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in micePLoS One201386e6707823825622
  • MengFTrivinoAPrasadDChauhanHInvestigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersionsEur J Pharm Sci201571122425686597
  • ZhaoLFangLXuYLiuSHeZZhaoYTransdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancersEur J Pharm Biopharm200869119921318065216
  • MahlerGJEschMBTakoEOral exposure to polystyrene nanoparticles affects iron absorptionNat Nanotechnol20127426427122327877
  • VogtACombadiereBHadamS40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skinJ Invest Dermatol200612661316132216614727
  • WuJKSillerGStruttonGPsoriasis induced by topical imiquimodAustralas J Dermatol2004451475014961909
  • SunLCunDYuanBFormulation and in vitro/in vivo correlation of a drug-in-adhesive transdermal patch containing azasetronJ Pharm Sci2012101124540454822972714
  • SunLLiuZWangLEnhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogelJ Control Release2017254445428344018
  • WenkersBPLippoldBCSkin penetration of nonsteroidal antiinflammatory drugs out of a lipophilic vehicle: influence of the viable epidermisJ Pharm Sci199988121326133110585230
  • ArimotoMFukumoriYFujikiJIchikawaHAcrylic terpolymer microcapsules for colon-specific drug delivery: effect of molecular weight and solubility of microencapsulated drugs on their release behaviorsJ Drug Deliv Sci Technol2006163173181
  • KokateALiXWilliamsPJSinghPJastiBRIn silico prediction of drug permeability across buccal mucosaPharm Res20092651130113919184372
  • BrodinANyqvist-MayerAWadstenTForslundBBrobergFPhase diagram and aqueous solubility of the lidocaineprilocaine binary systemJ Pharm Sci19847344814846726632
  • HoHOChenLCLinHMSheuMTPenetration enhancement by menthol combined with a solubilization effect in a mixed solvent systemJ Control Release1998512–33013119685928
  • DiasMHadgraftJLaneMEInfluence of membrane-solvent-solute interactions on solute permeation in skinInt J Pharm20073401–2657017467936
  • GaridelPFöltingBSchallerIKerthAThe microstructure of the stratum corneum lipid barrier: mid-infrared spectroscopic studies of hydrated ceramide:palmitic acid:cholesterol model systemsBiophys Chem20101501–314415620457485
  • XieXTaoQZouYPLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanismsJ Agric Food Chem201159179280928921797282
  • LademannJKnorrFRichterHHair follicles–an efficient storage and penetration pathway for topically applied substances. Summary of recent results obtained at the Center of Experimental and Applied Cutaneous Physiology, Charite -Universitatsmedizin Berlin, GermanySkin Pharmacol Physiol200821315015518523412